Same .....Dec 2018 CC big plans, 2019 rev estimates 250M/yr, 2019/20 Nasdaq listing , 2019 Altucell deal - still no closing.......all before Covid ....and now Covid is the big potential ....... C'mon man ..........money talks BS walks and they continue to walk. von Hofe is key and hopefully successful. Ego and ignorance appear to lead the way........of course a successful vaccine could change the pic but not the past .........we need solid experienced credible leadership !!!
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links